Tradition Wealth Management’s Defiance Nasdaq Junior Biotechnology ETF IBBJ Stock Holding History
Bought
Maintained
Sold
Tradition Wealth Management's IBBJ Position: Q4 2021 in Review
Tradition Wealth Management sold out of Defiance Nasdaq Junior Biotechnology ETF (IBBJ) in Q4 2021, closing a stake of 5,114 shares — an estimated $149K sold.
Tradition Wealth Management first reported a position in IBBJ in Q2 2021 and held it in 2 quarters. The position peaked at $149K in Q3 2021. 0 funds tracked by Wall St. Rank hold IBBJ as of Q4 2021.
- Tradition Wealth Management reported no remaining Defiance Nasdaq Junior Biotechnology ETF position as of Q4 2021 after selling out during the quarter.
- Tradition Wealth Management sold 5,114 Defiance Nasdaq Junior Biotechnology ETF shares in Q4 2021, an estimated $149K.
- Tradition Wealth Management first reported a position in Defiance Nasdaq Junior Biotechnology ETF in Q2 2021 and held it in 2 quarters.
- Tradition Wealth Management's Defiance Nasdaq Junior Biotechnology ETF position peaked at $149K in Q3 2021.
- 0 funds tracked by Wall St. Rank held Defiance Nasdaq Junior Biotechnology ETF as of Q4 2021.
Based on Tradition Wealth Management's 13F filing for Q4 2021, filed 14 Feb 2022.